Clinical Trial Update: First-in-Human, Multiple Part Clinical Study of JNT-517 in Healthy Participants and in Participants With Phenylketonuria [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports a first-in-human, multi-part Phase 1/2 study of JNT-517 in healthy participants and in individuals with phenylketonuria, spon…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Phenylketonuria

Drugs mentioned

• JNT-517

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Phenylketonuria | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING